Tag: #Global Trends

The U.S. Food and Drug Administration (FDA) has "proactively" awarded Johnson & Johnson (J&J) a Commissioner’s National Priority Voucher (CNPV)... Read more

The U.S. Food and Drug Administration (FDA) recently granted approval for a new combination regimen for patients with unresectable or... Read more

Occupational health specialist Concentra (NYSE:CON), a publicly traded company, has expanded its national footprint by establishing a new medical center... Read more

Zealand Pharma A/S and OTR Therapeutics have announced a strategic collaboration and license agreement focused on the discovery and development... Read more

China’s National Medical Products Administration (NMPA) has granted approvals for two of Sanofi's rare hematologic disease treatments: Qfitlia (fitusiran) and... Read more

Negotiators from the European Parliament (EP) and the EU Council have reached a provisional agreement on a new regulatory framework... Read more

The U.S. Food and Drug Administration (FDA) has granted an expanded indication for Amgen's monoclonal antibody, Uplizna (inebilizumab). The new... Read more

The U.S. Food and Drug Administration (FDA) has announced a decision to expand the usage approval for GSK’s antibiotic, Blujepa,... Read more

EAST HANOVER, December 12, 2025 – The global pharmaceutical corporation Novartis has commenced construction on its major strategic manufacturing center... Read more